In alignment with the Trump administration’s efforts to lower drug prices, Amgen today launched AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at a monthly price of $239, nearly ...

Amgen received a label expansion from the FDA in August 2025, with the VESALIUS-CV data supporting this decision.

Amgen makes Repatha available through AmgenNow, a direct-to-patient programme in the US: Thousand Oaks, California Wednesday, October 8, 2025, 17:00 Hrs [IST] Amgen announced the ...

Amgen’s phase 3 VESALIUS-CV trial meets primary endpoints in a cardiovascular primary prevention study of 12,000 patients: Thousand Oaks, California Saturday, October 4, 2025, 1 ...

The 12,000-patient trial of the PCSK9 inhibitor met its primary endpoints in high-risk individuals with no prior CV events.

Amgen (AMGN) stock is in focus as its cholesterol drug Repatha succeeds in a Phase 3 trial, reducing the risk of major ...

Washington — The Trump administration on Friday asked the Supreme Court to allow it to enforce for now its policy ending the use of the "X" marker on passports and requiring the documents to reflect ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

The U.S. Department of Education announced Friday that it has placed Harvard University on heightened cash monitoring as a result of "growing concerns" regarding its "financial position," the latest ...

In a dramatic reversal, Mayor Adams’ administration moved Thursday to kill a controversial plan to build a housing complex in the Bronx for former inmates with serious health issues that has sparked ...

A federal judge on Saturday said it appeared the Trump administration was making “an end run around” US court orders prohibiting five African immigrants to be deported to their home countries by ...